<DOC>
	<DOCNO>NCT02354196</DOCNO>
	<brief_summary>To determine total plaque burden , plaque severity composition patient undergoing Cardiac CT previous history CVD . There two cohort : 1 . A retrospective follow-up MACE endpoint patient underwent CCTA &gt; 1 year ago part Big PICTURE Trial , meet inclusion criterion Big PICTURE 2 . 2 . A prospective observational registry patient refer undergo CCTA 1 2 year follow-up .</brief_summary>
	<brief_title>Physicians International CT Utilization Registry 2</brief_title>
	<detailed_description>In original BIG PICTURE trial , analysis 6000 subject 's CCTA image find significant difference amongst patient Arabic south-east Asian descent , regard plaque burden , severity composition . Due `` all-comers '' nature trial , factor diabetes , previous CVD , coronary risk factor likely confounders result . In trial , subject selection screen eliminate factor goal work homogenous population perform plaque analysis . This study multicenter , prospective , post marketing , observational registry study design describe frequency pattern various risk factor , indication finding patient undergo CCTA . BIG PICTURE 2 ( abbreviate `` BP2 '' ) collect data patient wide variety image site ( inpatient , outpatient , in-clinic CT machine ) . While majority site within US , data collection limit US-only site . A sub study BP2 perform remote short follow-up questionnaire subject original Big PICTURE study .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Subject Inclusion Criteria 18 year old No prior CVD No hypertension No Diabetes Body mass index ( BMI ) &lt; 35 kg/m2 . Subject Exclusion Criteria &lt; 18 year old Prior CVD Hypertension Body mass index ( BMI ) &gt; =30 kg/m2 . Diabetes Mellitus Type 1 2 Current previous history smoking Pregnancy Planned intervention bypass surgery Known complex congenital heart disease Planned invasive angiography reason CAD Noncardiac illness life expectancy &lt; 2 year Inability provide write informed consent Concomitant participation another clinical trial subject subject investigational drug device Pregnant woman Allergy iodinate contrast agent Serum creatinine &gt; 1.5 mg/dl GFR &lt; 30 ml/min Baseline irregular heart rhythm Heart rate ≥100 beat per minute Systolic blood pressure ≤90 mm Hg Contraindications β blocker nitroglycerin Strategies Recruitment Retention</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>